(Endocrinology 137: 3744-3749, 1996) c XTENSIVE studies of the estrogen-stimulated maturaLj tion of the immature rat uter& have shown that the process is mediated by peptide growth factors whose expression is regulated by estradiol (EJ. All cell layers of the organ grow in response to E,, but the intermediary peptide growth factors provoke different responses in the different layers (reviewed in Ref. 1). We have postulated that thrombin is one such growth factor.
Thrombin is generated in situ by the activation of prothrombin through the coagulation cascade beginning with tissue factor (TF). In the unstimulated immature uterus, TF and prothrombin are present at low levels. A single injection of 30 pg E2/ kg administered to 19-to Z-day-old rats results in a 3-to 4-fold increase in the amount of prothrombin (2,3) and the expression of TF (4,5) in the uterus within 3 h. The combination of the two permits the generation of thrombin in the uterus at a time when estrogen-stimulated growth is beginning. We have postulated that thrombin can act as a growth factor under these circumstances (6).
Thrombin stimulates growth in a wide variety of cells. The extent of stimulation and the most effective thrombin dose are highly variable. In some types of cells, thrombin acts directly as a mitogen. In other cells, thrombin has been found to potentiate other growth factors or to cause increases in the amounts of such growth factors as basic fibroblast growth factor (7, 8) .
Thrombin acts as a growth factor through a G proteincoupled thrombin receptor (THREC) (9). The mechanism of activation of the receptor is unique: thrombin binds to the amino-terminal of the receptor and by proteolytic cleavage at R41-S42 exposes a new amino-terminal (the tethered peptide), which then binds to an independent site that may be in the second extracellular loop of the receptor (lo), causing activation. An additional region, residues 83-94, may also be involved in activation (11).
The effects of thrombin mediated by THREC can be elicited by thrombin receptor-activating peptides (TRAPS) of the same sequence as the tethered peptide (10,12,13). The minimum requirement for a response is the 6-residue sequence SFFLRN (rTRAP-6). Most studies have been performed with the 14-residue TRAP; for the rat, that sequence (rTRAP) is SFFLRNPSEDTFEQ (14). Thousand-fold higher concentrations of rTRAP-6 or rTRAP are generally required to give responses equivalent to those to thrombin.
We report here that THREC is present in the immature rat uterus before estrogen stimulation, and we show that thrombin is a growth factor for isolated uterine stromal cells in primary culture. That thrombin acts through the proteolytitally activated THREC is shown by the growth response to TRAP; that catalytically active thrombin is required is shown by the prevention of the growth response by hirudin, a specific inhibitor of thrombin's proteolytic activity, and by the failure of active site-inhibited thrombin to elicit the growth response. This evidence demonstrates the presence in the uterus of a complete functional thrombin growth factor receptor system that can mediate estrogen-stimulated growth. 
Results

Demonstration of thrombin receptor in uterine cells
XT-PCR for THREC. To demonstrate the presence of messenger RNA for THREC in the uterus, total RNA was prepared and reverse transcribed as described in Materials and Methods. The PCR reaction was performed with primers designed to give a 497-bp fragment of THREC from the 3'-end of the complementary DNA, residues 2068-2566 (14) . This fragment contained two sites for the restriction endonuclease PvuII; reaction with PvtlII resulted in the generation of fragments of 255, 148, and 94 bp. As shown in Fig. 1 , a DNA fragment of the predicted size was obtained in the PCR reaction; after digestion with PvuII, the three predicted bands were seen. The experiment was repeated with isolated stroma1 and epithelial cells that had been cultured to confluence. The reaction was positive for both types of cells, also shown in Fig. 1 .
[1251]TRAP labeling of uterine membranes. To identify a specific TRAP-binding protein, we used uterine membrane preparations and [ ] lz51 hTRAP After a l-h incubation, the reactants . were cross-linked and electrophoresed on SDS-acrylamide gels. The gels were dried and exposed to x-ray film. As shown in Fig. 2 , a band of about 79 kDa was labeled. The labeled band was somewhat larger than the expected size for THREC (19) . Two experiments are shown in Fig. 2 Freshly prepared rat platelets were washed briefly and sonicated in buffer with soybean trypsin inhibitor and aprotinin. Uterine membranes were prepared as previously described (17). Thirty micrograms of protein were used for each sample. After the samples were transferred to nitrocellulose, protein A-purified antibody Xl67 was incubated with the blots for 2 h. The blots were developed with alkaline phosphatase-coupled second antibody. Lanes 1 and 2, Xl67 diluted 50-fold; lanes 3 and 4, Xl67 diluted 50-fold and competed with 10 pM i-TRAP. Lanes 1 and 3, Uterine membranes; lanes 2 and 4, platelets. The molecular masses of the standards are given on the left; the arrows on the right indicate the positions of the receptor bands. The bands at the top of each lane reflect nonspecific reactions of the antibody with protein aggregates.
followed by enzyme-linked immunosorbent assay with the peptide and with preparations of THREC expressed in a baculovirus-insect cell system. Details of the expression of THREC in this system will be published elsewhere. The antibody reacted specifically with THREC in Western blots of the expressed protein.
The specificity of protein A-purified antibody Xl67 for THREC in freshly prepared rat platelets and the reaction of the antibody with a protein in uterine membrane preparations are both shown in a Western blot in Fig. 3 . Aliquots of 30 Fg of a freshly prepared rat platelet extract and of stromal cell membrane preparations were electrophoresed and transferred to nitrocellulose. Antibody Xl67 gave a single faint band for the platelet receptor (Fig. 3, lane 2) at about 65 kDa, similar to the band for THREC in human platelets shown in a Western blot by Brass et al. (19) . The rat uterine cell extract also gave a positive band in the Western blot, shown in lane 1. The apparent molecular mass (-60 kDa) is slightly smaller than that of platelet protein. Lane 1 also shows a very faint band at about 45 kDa that is probably a breakdown product of the receptor. When the antibody was competed with TRAP peptide (lanes 3 and 4) , only nonspecific staining of high molecular mass aggregates was seen.
Comigration of thrombin and THREC in uterine membranes. The faint bands in Fig. 3 led us to seek additional confirmation of the presence of THREC in uterine membranes. If thrombin were generated in the uteri of E,-treated animals, it would bind to THREC, and the thrombin-THREC complex should comigrate to a higher molecular mass position in a gel if the two were cross-linked. Such a complex from uterus would be predicted to have a molecular mass between 90-100 kDa (37 kDa for thrombin and 55-65 kDa for THREC). Treatment of the rats with E, would result in an influx of plasma proteins, including prothrombin, into the uterus, where thrombin could be generated. Thus, if E,-treated rats were used, no exogenous thrombin would be required in this experiment. Accordingly, membranes were prepared from the uteri of rats treated with E,. Samples were cross-linked with bis-[sulfosuccinimidyl] suberate, electrophoresed on a SDS gel, and transferred to nitrocellulose. The blot was incubated with an antithrombin antibody (Binding Site, San Diego, CA). Figure 4 shows the results. In lane 1, the primary antithrombin antibody was competed with PPACK-thrombin; in lane 2, the antibody was not competed. A specific band was clearly visible at 90-100 kDa.
Thrombin-stimulated cell growth
Thrombin us a growth factor. The stimulation of stromal cell growth by thrombin was shown in nearly confluent cultures of stromal cells that were depleted of serum for 24 h and then grown in ITS medium with human thrombin and [3H]thymidine for 48 h. Analysis of the TCA-precipitable DNA showed that the addition of thrombin resulted in a 2-fold stimulation of growth of the stromal cells. The thrombin concentration curve shown in Fig. 5 reveals a maximum response at 50-150 XIM thrombin.
The nature of the thrombin growth response was further defined in additional growth experiments, shown in Fig. 6 . The relative growth rates of the cultures, compared to their growth rates in ITS medium, are given. Only 100 nM thrombin produced a significant increase in [3H]thymidine incorporation. The addition of 350 U of the highly specific thrombin inhibitor hirudin to the medium prevented thrombinstimulated growth, whereas hirudin alone had no effect on growth. The catalytically inactive PPACK-thrombin did not stimulate growth.
Growth with rTRAP.
Thrombin stimulation mediated by THREC was also obtained with TRAP. Stromal cell cultures were stimulated to grow by 50-100 pM rTRAP. Figure 7 shows the rTRAP concentration curve for growth; the maximal response was achieved with concentrations higher than 50 PM. The magnitude of the response was similar to that of the response to 50 nM thrombin.
Discussion
The presence of THREC in immature rat uterine membrane preparations and the stimulation of growth of stromal cells in culture by thrombin and rTRAP are good evidence that thrombin is a growth factor for this organ (13, 20) . There are three lines of evidence for the presence of THREC in the uterus: RT-PCR, specific binding of radiolabeled rTRAP, and immunoreactivity with a specific rTRAP-directed antibody. The RT-PCR experiment shows that THREC messenger RNA is expressed in the uterus. Because of the very high sensitivity of the RT-PCR procedure, this positive result with total uterine RNA could have come from the amplification of RNA from monocytes, macrophages, eosinophils, or endo- thelial cells that may have been present in the preparations (21). Therefore, we repeated the experiment with RNA prepared from cultured uterine epithelial and stromal cells. Positive results were obtained from both cultures. Stromal cultures are unlikely to be contaminated with epithelial cells because the initial low level of epithelial contamination is rapidly overgrown by the stroma. On the other hand, epithelial cultures are likely to be contaminated with stromal cells. Therefore, we conclude that stromal cells definitely contain THREC, and epithelial cells may also express receptor.
The proof that THREC protein is present in the uterus is somewhat more difficult. Specific labeling of THREC by radiolabeled thrombin is problematic. Thrombin has high nonspecific binding, THREC is present in low concentration, and in addition to THREC, thrombomodulin and protease nexin in the cell membrane will also specifically bind thrombin (22, 23) . As thrombin binding experiments are not definitive, we used demonstration of the specific binding of [iz51]hTRAP to uterine membrane preparations as a proof of the presence of THREC.
The reaction of [iz51]hTRAP with a specific band in rat uterine membrane preparations also indicated the presence of the receptor in the uteri before hormonal stimulation, as these labeling studies were performed with membrane preparations from unstimulated rats. The size of the labeled band (-65-70 kDa) was somewhat larger than that of the band in Western blots. The apparent difference in size is attributable to the different molecular mass standards used in the experiments. Labeling with TRAP is diagnostic for the proteolytically activated thrombin receptor. Immunological studies of THREC used polyclonal antibodies to rTRAP, which revealed a THREC of somewhat different molecular mass (60-67 kDa) in platelets and uterine membranes. These differences may be due to incomplete protease inhibition or differences in glycosylation of the receptor.
Our earlier immunohistochemical
and enzymatic studies (3) showed that after estrogen stimulation, thrombin levels in the stroma are increased. Thrombin must bind to the receptor if it is to signal mitogenesis. After an appropriate incubation and cross-linking step, a thrombin-receptor complex was indicated on the Western blot by the specific staining of a band of 90-100 kDa. The indicated molecular mass of the receptor was 53-63 kDa, in the same size range as the human receptor (19) and the rat receptor shown in Fig. 3 .
An early dramatic effect of estrogen stimulation in the immature rodent uterus is a 50% increase in wet weight within 3 h, which is the result of the imbibition of water and plasma proteins (24). It is this imbibition that increases the prothrombin concentration in the uterus. The concomitant induction of tissue factor (3) permits thrombin to be generated in situ.
The stimulation of stromal cell growth by catalytically active thrombin and TRAP is the final proof that thrombin is a growth factor for these cells. The growth rate was doubled with 50-150 nM thrombin. The optimum thrombin concentration for growth stimulation is generally in the l-100 nM range, but varies widely in different types of cells. Mitogenesis in CCL39 hamster fibroblasts is a maximum at 100 nM thrombin (8); rat vascular smooth muscle cells respond to 140 nM thrombin (12); the growth of human umbilical vein endothelial cell is stimulated lo-fold by 1000 nM thrombin (7). Belloni et al. (25) found that microvascular cells from mouse brain, lung, and liver all responded to thrombin; cell number increased 2-to 3-fold in 4 days with 1.4-270 nM thrombin. Among cells that are not part of the circulatory system, rat astrocytes have an ECso of 0.5 nM for growth stimulation (26); T47D epithelial breast tumor cells are maximally stimulated by 4-5 nM thrombin (27).
Stimulation of growth by rTRAP confirmed that the proteolytically activated thrombin receptor was involved in the growth response. Growth was doubled at lo-25 FM TRAP and was increased nearly 3-fold at 100 PM rTRAP. Growth stimulation by TRAP occurred at similar concentrations in vascular smooth muscle cells (12,28), human umbilical vein endothelial cells (7), and fibroblasts (29).
Our initial hypothesis (6) was that thrombin action in the uterus involved multiple steps; E,-stimulated induction of TF and infiltration of prothrombin would permit the local uterine generation of thrombin, which could act as a growth factor. This hypothesis is now shown to be correct. The remaining question is whether the growth stimulatory effect of thrombin is significant, in view of all of the growth factors known to be present in the uterus after estrogen stimulation. These include epidermal growth factor (EGF), transforming growth factor-a, and insulin-like growth factors (IGFs).
EGF is clearly very important as an estrogen-mediated growth factor in uterine epithelial cells (30) in rodents (31, 32) . However, the effects of EGF are directed primarily toward the epithelial cells rather than the stromal cells (32). Transforming growth factor-a, which acts through the EGF receptor, is increased in the immature mouse uterus by E, and, like EGF, affects primarily the epithelial cells (33).
IGF-I and its receptor are estrogen inducible in the immature rat uterus; they are found in stromal cells (34), but are primarily myometrial (35). In rat uterine slices, IGF-I in-creased DNA synthesis 1.5-to 1.6-fold in the stroma compared to that in untreated controls, but only if a high level (10e6 M) of E, was present (35).
Fibroblast growth factor is also present in the uterus (1) and may play a role in angiogenesis there (36), although its role in uterine development is much less studied.
It is unlikely that any single growth factor would be both necessary and sufficient for E,-stimulated uterine growth; extensive redundancy is much more likely. A very recent report (37) studied transgenic mice that overexpress IGFbinding protein-l. These mice had reduced uterine DNA synthesis and weight gain in response to E,; they also had a 20-30% reduction in litter size. These results indicate that although IGF-I is an important factor in uterine development and fertility, development can occur when the IGF-I concentration is greatly reduced.
Thrombin could fill a particular niche in uterine development, as it could be available in the uterus by generation from prothrombin as rapidly as the E,-stimulated imbibition of plasma will permit. The fact that THREC is present before E, stimulation suggests that thrombin could play an important role by providing the initial stimulus for uterine stromal mitogenesis through its preexisting receptors.
